Rezolute Stock News & Updates
[WKN: A2QEWP | Symbol: RZLT]
Rezolute: Breakthrough in Phase 3 Study Opens Transformation to a Commercial Biotech Player - Maxim Sees 222% Price Potential for the Stock!
The release of convincing interim data from the Phase 3 clinical study "upLIFT" has brought the stock...
Rezolute: The bet on Rare Diseases: How the Company Plans to Conquer the Market with its Orphan Drug Candidate RZ358
Rezolute is a biopharmaceutical company developing therapies for rare and metabolic diseases. ...
Analysts' Top 5 Price Targets of October 29, 2025
Nvidia [US67066G1040] Cantor Fitzgerald reaffirms the Overweight rating with a price target...
- ‹
- 1
- ›